ArticleEnvironmental analysis, health and toxicology2025
The effect of an organophosphorus pesticide, chlorpyrifos (from different local sources), on the testicular tissue in adult male albino rats.
Article in Environmental analysis, health and toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Synergistic reproductive toxicity of lambda-cyhalothrin and thiamethoxam via oxidative stress and blood-testis barrier dysfunction in rats.Scientific reports · 2026Article
- Molecular insights into the protective role of nano-naringin in mancozeb-induced testicular damage and infertility.Biological research · 2026Article
- Reproductive toxicity of a nano-insecticide (chlorpyrifos) on male albino mice.Scientific reports · 2026Article
- Jojoba Oil Protects against Chlorpyrifos-Induced Testicular Toxicity by Modulating Notch1/Jagged1-Inflammatory Axis and Oxidative Stress.Cell biochemistry and biophysics · 2026Article
- Therapeutic effect of naringenin against fenamiphos‑induced testicular damage in male rats: a histological and biochemical study.Journal of molecular histology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlorpyrifos is a widely used organophosphorus pesticide for agricultural purposes to control early disease in crops. Acting as an endocrine disrupting agent for male reproductive systems which leads to reproductive toxicity. Accordingly, this study aimed to investigate the potential mechanisms by which three commercial formulations of chlorpyrifos interfere with androgen receptor function and expression in male rats. The research was conducted according to the ethical guidelines established by the institutional animal care and use committee (IACUC), and the protocol received approval from Cairo University- Faculty of Science under approval number (CU/IF/12/23). Twenty-four male Wistar rats were equally allocated to four groups. The control group, chlorpyrifos groups orally received (17.43, 23.43, 21.40 mg/kg) for 28 days (5 days /week). The serum testosterone hormone was estimated, and the testes were collected, and fixed in 10% buffered formalin for histopathological and immunohistochemical examination. Results indicated that chlorpyrifos formulations caused a marked decrease in testosterone levels and downregulation of androgen receptor expression. Moreover, a significant reduction in tubular diameter, lumen diameter, and thickness of germinal epithelial cells was detected along with the Jonson score. In summary, exposure to the three chlorpyrifos formulations resulted in notable alterations in testosterone levels, decreased expression of androgen receptors, and compromised spermatogenesis, culminating in testicular damage and male infertility. Of the formulations assessed, chlorpyrifos-W was identified as the most effective disruptor of androgen signalling, demonstrating higher toxicity compared to the other formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.